Sector
HealthcareOpen
₹19.77Prev. Close
₹19.39Turnover(Lac.)
₹12.64Day's High
₹19.77Day's Low
₹19.7552 Week's High
₹28.952 Week's Low
₹9.8Book Value
₹22.97Face Value
₹10Mkt Cap (₹ Cr.)
8.56P/E
20.57EPS
0.96Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 4.33 | 4.33 | 4.33 | 4.33 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 5.21 | 4.59 | 6.15 | 5.22 |
Net Worth | 9.54 | 8.92 | 10.48 | 9.55 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 9.77 | 6.1 | 5.26 | 2.78 |
yoy growth (%) | 60.22 | 16.02 | 88.81 | |
Raw materials | -3.6 | -1.14 | -0.6 | -0.62 |
As % of sales | 36.87 | 18.77 | 11.51 | 22.44 |
Employee costs | -0.68 | -0.86 | -0.94 | -0.49 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 1.37 | 0.66 | 0.71 | 0.35 |
Depreciation | -0.51 | -0.42 | -0.34 | -0.13 |
Tax paid | -0.36 | -0.18 | -0.18 | -0.09 |
Working capital | 1.08 | 1.29 | 1.99 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.22 | 16.02 | 88.81 | |
Op profit growth | 74.85 | 5.87 | 94.57 | |
EBIT growth | 101.4 | -1.11 | 66.42 | |
Net profit growth | 113.25 | -11.11 | 103.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,266.35 | 162.98 | 1,23,107.82 | 177.39 | 0.12 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,101.65 | 78.77 | 1,02,110.83 | 333.4 | 0.39 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 790.9 | 465.24 | 59,709.64 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 2,070.8 | 98.14 | 42,319.04 | 159.98 | 0.22 | 919.03 | 106.95 |
Aster DM Healthcare Ltd ASTERDM | 596.6 | 5.25 | 30,911.1 | 61.07 | 19.88 | 573.86 | 79.8 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Arjan Lalchandani
Whole Time Director & CEO
Mohit Lalchandani
Executive Director & CFO
Anchal Gupta
Independent Director
Rajiv Handa
Independent Director
Prakash Jhuraney
Non Executive Director
Swati Chandra
M-20 Basement,
Greater Kailash-1,
New Delhi - 110048
Tel: 91-11-49057058
Website: -
Email: [email protected]
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: [email protected]
Summary
Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership F...
Read More
Reports by Dr Lalchandani Labs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.